A LigA three-domain region protects hamsters from lethal infection by Leptospira interrogans
- PMID: 22180800
- PMCID: PMC3236721
- DOI: 10.1371/journal.pntd.0001422
A LigA three-domain region protects hamsters from lethal infection by Leptospira interrogans
Abstract
The leptospiral LigA protein consists of 13 bacterial immunoglobulin-like (Big) domains and is the only purified recombinant subunit vaccine that has been demonstrated to protect against lethal challenge by a clinical isolate of Leptospira interrogans in the hamster model of leptospirosis. We determined the minimum number and location of LigA domains required for immunoprotection. Immunization with domains 11 and 12 was found to be required but insufficient for protection. Inclusion of a third domain, either 10 or 13, was required for 100% survival after intraperitoneal challenge with Leptospira interrogans serovar Copenhageni strain Fiocruz L1-130. As in previous studies, survivors had renal colonization; here, we quantitated the leptospiral burden by qPCR to be 1.2×10(3) to 8×10(5) copies of leptospiral DNA per microgram of kidney DNA. Although renal histopathology in survivors revealed tubulointerstitial changes indicating an inflammatory response to the infection, blood chemistry analysis indicated that renal function was normal. These studies define the Big domains of LigA that account for its vaccine efficacy and highlight the need for additional strategies to achieve sterilizing immunity to protect the mammalian host from leptospiral infection and its consequences.
Conflict of interest statement
The authors have read the journal's policy and have the following conflicts: Authors D.A.H. and J.M. are coinventors on United States Patent 7935357.
Figures
Similar articles
-
Immunoprotective properties of recombinant LigA and LigB in a hamster model of acute leptospirosis.PLoS One. 2017 Jul 13;12(7):e0180004. doi: 10.1371/journal.pone.0180004. eCollection 2017. PLoS One. 2017. PMID: 28704385 Free PMC article.
-
Oral immunization with Escherichia coli expressing a lipidated form of LigA protects hamsters against challenge with Leptospira interrogans serovar Copenhageni.Infect Immun. 2014 Feb;82(2):893-902. doi: 10.1128/IAI.01533-13. Epub 2013 Dec 9. Infect Immun. 2014. PMID: 24478102 Free PMC article.
-
A conserved region of leptospiral immunoglobulin-like A and B proteins as a DNA vaccine elicits a prophylactic immune response against leptospirosis.Clin Vaccine Immunol. 2013 May;20(5):725-31. doi: 10.1128/CVI.00601-12. Epub 2013 Mar 13. Clin Vaccine Immunol. 2013. PMID: 23486420 Free PMC article.
-
Expansion of the in vitro assay for Leptospira potency testing to other serovars: case study with Leptospira Hardjo.Biologicals. 2013 Sep;41(5):323-4. doi: 10.1016/j.biologicals.2013.06.003. Epub 2013 Jul 6. Biologicals. 2013. PMID: 23838569 Review.
-
Leptospiral Immunoglobulin-Like Domain Proteins: Roles in Virulence and Immunity.Front Immunol. 2021 Jan 8;11:579907. doi: 10.3389/fimmu.2020.579907. eCollection 2020. Front Immunol. 2021. PMID: 33488581 Free PMC article. Review.
Cited by
-
Genetic Analysis of LigA, LipL32, Loa22, and OmpL1 Antigens from Leptospira spp. Sejroe Serogroup: How Close We Are To a Vaccine Against Bovine Leptospirosis?Curr Microbiol. 2023 Aug 3;80(9):310. doi: 10.1007/s00284-023-03414-w. Curr Microbiol. 2023. PMID: 37535179
-
Challenges and Strategies for Developing Recombinant Vaccines against Leptospirosis: Role of Expression Platforms and Adjuvants in Achieving Protective Efficacy.Pathogens. 2023 May 31;12(6):787. doi: 10.3390/pathogens12060787. Pathogens. 2023. PMID: 37375478 Free PMC article. Review.
-
Leptospira borgpetersenii Leucine-Rich Repeat Proteins Provide Strong Protective Efficacy as Novel Leptospiral Vaccine Candidates.Trop Med Infect Dis. 2022 Dec 22;8(1):6. doi: 10.3390/tropicalmed8010006. Trop Med Infect Dis. 2022. PMID: 36668913 Free PMC article.
-
LigA formulated in AS04 or Montanide ISA720VG induced superior immune response compared to alum, which correlated to protective efficacy in a hamster model of leptospirosis.Front Immunol. 2022 Oct 10;13:985802. doi: 10.3389/fimmu.2022.985802. eCollection 2022. Front Immunol. 2022. PMID: 36300125 Free PMC article.
-
Challenges for the development of a universal vaccine against leptospirosis revealed by the evaluation of 22 vaccine candidates.Front Cell Infect Microbiol. 2022 Oct 7;12:940966. doi: 10.3389/fcimb.2022.940966. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36275031 Free PMC article.
References
-
- Levett PN. Leptospirosis. In: Emmerson A, Hawkey P, Gillespie S, editors. Principles and Practice of Clinical Bacteriology. Edinburgh; 1997. pp. 677–690.
-
- Hartskeerl RA, Collares-Pereira M, Ellis WA. Emergence, control and re-emerging leptospirosis: dynamics of infection in the changing world. Clin Microbiol Infect. 2011;17:494–501. - PubMed
-
- WHO . Geneva, Switzerland: WHO; 2003. Human leptospirosis: Guidance for diagnosis, surveillance and control.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
